Suppr超能文献

体外模型分析连续雾化时高流量气溶胶输送。

In Vitro Model for Analysis of High-Flow Aerosol Delivery During Continuous Nebulization.

机构信息

Pulmonary, Critical Care and Sleep Medicine Division, Department of Medicine, Stony Brook University Medical Center, Stony Brook, New York.

出版信息

Respir Care. 2023 Sep;68(9):1213-1220. doi: 10.4187/respcare.10643. Epub 2023 May 30.

Abstract

BACKGROUND

To understand the fate of aerosols delivered by high-flow nasal cannula using continuous nebulization, an open-source anatomical model was developed and validated with a modified real-time gamma ratemeter technique. Mass balance defined circuit losses. Responsiveness to infusion rate and device technology were tested.

METHODS

A nasal airway cast derived from a computed tomography scan was converted to a 3-dimensional-printed head and face structure connected to a piston ventilator (breathing frequency 30 breaths/min, tidal volume 750 mL, duty cycle 0.50). For mass balance experiments, saline mixed with Technetium-99m was infused for 1 h. Aerosol delivery was measured using a gamma ratemeter oriented to an inhaled mass filter at the hypopharynx of the model. Background and dead-space effects were minimized. All components were imaged by scintigraphy. Continuous nebulization was tested at infusion rates of 10-40 mL/h with gas flow of 60 L/min using a breath-enhanced jet nebulizer (BEJN), and a vibrating mesh nebulizer. Drug delivery rates were defined by the slope of ratemeter counts/min (CPM/min) versus time (min).

RESULTS

The major source of aerosol loss was at the nasal interface (∼25%). Significant differences in deposition on circuit components were seen between nebulizers. The nebulizer residual was higher for BEJN ( = .006), and circuit losses, including the humidifier, were higher for vibrating mesh nebulizer ( = .006). There were no differences in delivery to the filter and head model. For 60 L/min gas flow, as infusion pump flow was increased, the rate of aerosol delivery (CPM/min) increased, for BEJN from 338 to 8,111; for vibrating mesh nebulizer, maximum delivery was 2,828.

CONCLUSIONS

The model defined sites of aerosol losses during continuous nebulization and provided a realistic in vitro system for testing aerosol delivery during continuous nebulization. Real-time analysis can quantify effects of multiple changes in variables (nebulizer technology, infusion rate, gas flow, and ventilation) during a given experiment.

摘要

背景

为了了解高流量鼻导管输送的气溶胶在持续雾化时的命运,我们开发了一个开源解剖模型,并使用改良的实时γ射线率计技术对其进行了验证。质量平衡定义了回路损耗。测试了对输注率和设备技术的响应。

方法

从计算机断层扫描中获得的鼻气道模型被转换为 3 维打印的头部和面部结构,连接到活塞呼吸机(呼吸频率 30 次/分钟,潮气量 750 毫升,占空比 0.50)。为了进行质量平衡实验,将含有 Technetium-99m 的生理盐水输注 1 小时。使用面向模型下咽的γ射线率计测量气溶胶输送。背景和死腔效应最小化。所有组件均通过闪烁照相进行成像。使用呼吸增强射流雾化器(BEJN)和振动网孔雾化器,在 60 L/min 的气体流量下,以 10-40 mL/h 的输注率测试持续雾化。药物输送率由每分钟(CPM/min)与时间(min)的射线率计计数斜率定义。

结果

气溶胶损失的主要来源是在鼻接口处(约 25%)。不同雾化器在回路组件上的沉积存在显著差异。BEJN 的雾化器残留量较高( =.006),振动网孔雾化器的回路损失(包括加湿器)较高( =.006)。对过滤器和头部模型的输送没有差异。对于 60 L/min 的气体流量,随着输注泵流量的增加,气溶胶输送率(CPM/min)增加,BEJN 从 338 增加到 8,111;对于振动网孔雾化器,最大输送量为 2,828。

结论

该模型定义了连续雾化时气溶胶损失的部位,并为连续雾化时气溶胶输送的测试提供了一个现实的体外系统。实时分析可以定量分析在给定实验中多种变量(雾化器技术、输注率、气体流量和通气)变化的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验